Literature DB >> 14994141

Gastrointestinal carcinoid tumors: factors that predict outcome.

Jamie J Van Gompel1, Rebecca S Sippel, Tom F Warner, Herbert Chen.   

Abstract

Gastrointestinal (GI) carcinoids are neuroendocrine tumors originating in multiple locations throughout the GI tract. The prognosis for patients with GI carcinoid tumors is diverse. To determine the factors that significantly affect prognosis, we reviewed our experience. Between 1992 and 2000 a total of 70 patients with GI carcinoid tumors underwent surgical resection at our institution. The patients were grouped into three categories based on the origin of the carcinoid tumor: foregut, midgut, hindgut. The mean age of the patients was 56 +/- 2 years. All patients with foregut carcinoids had symptoms upon presentation, whereas 61% of those with midgut carcinoids and only 37% of those with hindgut carcinoids had symptoms ( p < 0.001). The factors that most strongly affected survival on univariate analysis were a symptomatic presentation and the site of origin. Patients with foregut or midgut lesions had lower 5-year disease-free survivals than those with hindgut tumors. Moreover, the size of the primary tumor and the presence of liver metastases were not independent predictors of survival. Despite the larger tumor size and the higher incidence of liver metastases, patients with foregut carcinoids appear to have the same prognosis as those with midgut carcinoids. These data therefore suggest that the outcomes of patients with carcinoid tumors are highly dependent on the presence of symptoms and the site of origin.

Entities:  

Mesh:

Year:  2004        PMID: 14994141     DOI: 10.1007/s00268-003-7019-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

1.  Carcinoid tumors; a report of 38 cases.

Authors:  R C FOREMAN
Journal:  Ann Surg       Date:  1952-11       Impact factor: 12.969

2.  Foregut carcinoids: a clinical and biochemical analysis.

Authors:  P M Kirshbom; A R Kherani; M W Onaitis; A Hata; T E Kehoe; C Feldman; J M Feldman; D S Tyler
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

3.  Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center.

Authors:  E T Janson; L Holmberg; M Stridsberg; B Eriksson; E Theodorsson; E Wilander; K Oberg
Journal:  Ann Oncol       Date:  1997-07       Impact factor: 32.976

4.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

5.  Carcinoid tumors of the gastrointestinal tract: a 44-year experience.

Authors:  S Saha; S Hoda; R Godfrey; C Sutherland; K Raybon
Journal:  South Med J       Date:  1989-12       Impact factor: 0.954

6.  Carcinoid tumors of the gastrointestinal tract.

Authors:  Y M Zakariai; S H Quan; S I Hajdu
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

7.  Carcinoid tumours of the appendix: 21 cases, with a review of the literature.

Authors:  J P Dunn
Journal:  N Z Med J       Date:  1982-02-10

8.  Carcinoids and the carcinoid syndrome.

Authors:  T H Wareing; J L Sawyers
Journal:  Am J Surg       Date:  1983-06       Impact factor: 2.565

9.  Carcinoid tumor of the appendix: treatment and prognosis.

Authors:  C G Moertel; L H Weiland; D M Nagorney; M B Dockerty
Journal:  N Engl J Med       Date:  1987-12-31       Impact factor: 91.245

10.  Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis.

Authors:  G B Thompson; J A van Heerden; J K Martin; A J Schutt; D M Ilstrup; J A Carney
Journal:  Surgery       Date:  1985-12       Impact factor: 3.982

View more
  24 in total

1.  Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.

Authors:  Matthew Truong; Mackenzie R Cook; Scott N Pinchot; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2010-12-24       Impact factor: 5.344

Review 2.  The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors.

Authors:  Yash R Somnay; Muthusamy Kunnimalaiyaan
Journal:  Glob J Biochem       Date:  2011-03-08

3.  Raf-1 activation in gastrointestinal carcinoid cells decreases tumor cell adhesion.

Authors:  David Yü Greenblatt; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Am J Surg       Date:  2007-03       Impact factor: 2.565

4.  Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells.

Authors:  David Yu Greenblatt; Max Cayo; Li Ning; Renata Jaskula-Sztul; Megan Haymart; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  J Gastrointest Surg       Date:  2007-09-15       Impact factor: 3.452

5.  Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center.

Authors:  Ozcan Yildiz; Mustafa Ozguroglu; Teoman Yanmaz; Hande Turna; Suheyla Serdengecti; Gulen Dogusoy
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

6.  Small bowel carcinoid: a rare cause of bowel obstruction.

Authors:  Gabriel Rodrigues; Raghunath Prabhu; Bharadwaj Ravi
Journal:  BMJ Case Rep       Date:  2013-09-24

7.  Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.

Authors:  Joel T Adler; Daniel G Hottinger; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2008-11-22       Impact factor: 5.344

Review 8.  Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors.

Authors:  Scott N Pinchot; Susan C Pitt; Rebecca S Sippel; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Curr Opin Investig Drugs       Date:  2008-06

9.  Nonlinear optical microscopy for label-free detection of gastrointestinal neuroendocrine tumors.

Authors:  Lianhuang Li; Liwei Jiang; Zhifen Chen; Deyong Kang; Zhenrong Yang; Xing Liu; Weizhong Jiang; Shuangmu Zhuo; Guoxian Guan; Yongjian Zhou; Jianxin Chen
Journal:  Lasers Med Sci       Date:  2016-06-14       Impact factor: 3.161

10.  Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors.

Authors:  Susan C Pitt; Herbert Chen; Muthusamy Kunnimalaiyaan
Journal:  Ann Surg Oncol       Date:  2009-07-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.